These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18400475)

  • 1. Characterization of the grinding behaviour in a single particle impact device: studies on pharmaceutical powders.
    Meier M; John E; Wieckhusen D; Wirth W; Peukert W
    Eur J Pharm Sci; 2008 May; 34(1):45-55. PubMed ID: 18400475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of nanomechanical crystal properties on the comminution process of particulate solids in spiral jet mills.
    Zügner S; Marquardt K; Zimmermann I
    Eur J Pharm Biopharm; 2006 Feb; 62(2):194-201. PubMed ID: 16202574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a novel approach towards predicting the milling behaviour of pharmaceutical powders.
    Kwan CC; Chen YQ; Ding YL; Papadopoulos DG; Bentham AC; Ghadiri M
    Eur J Pharm Sci; 2004 Dec; 23(4-5):327-36. PubMed ID: 15567285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a jet mill for dispersing dry powder for inhalation studies.
    Cheng YS; Marshall TC; Henderson RF; Newton GJ
    Am Ind Hyg Assoc J; 1985 Aug; 46(8):449-54. PubMed ID: 4050682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of DMA for the detection of amorphous content in pharmaceutical powdered materials.
    Royall PG; Huang CY; Tang SW; Duncan J; Van-de-Velde G; Brown MB
    Int J Pharm; 2005 Sep; 301(1-2):181-91. PubMed ID: 16026947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A method for grindability testing using the Scirocco disperser.
    Bonakdar T; Ali M; Dogbe S; Ghadiri M; Tinke A
    Int J Pharm; 2016 Mar; 501(1-2):65-74. PubMed ID: 26827923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of crystal imperfections on particle fracture behaviour.
    de Vegt O; Vromans H; Pries W; van der Voort Maarschalk K
    Int J Pharm; 2006 Jul; 317(1):47-53. PubMed ID: 16597489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triboelectrification of pharmaceutical powders by particle impact.
    Watanabe H; Ghadiri M; Matsuyama T; Ding YL; Pitt KG; Maruyama H; Matsusaka S; Masuda H
    Int J Pharm; 2007 Apr; 334(1-2):149-55. PubMed ID: 17141989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A; Boireau H; Horta MJ; Vanbever R
    Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Batch grinding kinetics of Ethenzamide particles by fluidized-bed jet-milling.
    Fukunaka T; Golman B; Shinohara K
    Int J Pharm; 2006 Mar; 311(1-2):89-96. PubMed ID: 16427749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between cascade impactor analysis and laser diffraction techniques for the determination of the particle size of aerosolised powder formulations.
    Pilcer G; Vanderbist F; Amighi K
    Int J Pharm; 2008 Jun; 358(1-2):75-81. PubMed ID: 18359587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-infrared spectroscopic method for real-time monitoring of pharmaceutical powders during voiding.
    Barajas MJ; Cassiani AR; Vargas W; Conde C; Ropero J; Figueroa J; Romañach RJ
    Appl Spectrosc; 2007 May; 61(5):490-6. PubMed ID: 17555618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving flow properties of ibuprofen by fluidized bed particle thin-coating.
    Ehlers H; Räikkönen H; Antikainen O; Heinämäki J; Yliruusi J
    Int J Pharm; 2009 Feb; 368(1-2):165-70. PubMed ID: 19010403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design.
    Guenette E; Barrett A; Kraus D; Brody R; Harding L; Magee G
    Int J Pharm; 2009 Oct; 380(1-2):80-8. PubMed ID: 19596428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between drained angle and flow rate of size fractions of powder excipients.
    Sklubalová Z; Zatloukal Z
    Pharmazie; 2009 Dec; 64(12):846-7. PubMed ID: 20095146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive monitoring of the mixing of pharmaceutical powders by broadband acoustic emission.
    Allan P; Bellamy LJ; Nordon A; Littlejohn D
    Analyst; 2010 Mar; 135(3):518-24. PubMed ID: 20174704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of particle properties on the flowability of ibuprofen powders.
    Liu LX; Marziano I; Bentham AC; Litster JD; White ET; Howes T
    Int J Pharm; 2008 Oct; 362(1-2):109-17. PubMed ID: 18652883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel description of a design space for fluidised bed granulation.
    Lipsanen T; Antikainen O; Räikkönen H; Airaksinen S; Yliruusi J
    Int J Pharm; 2007 Dec; 345(1-2):101-7. PubMed ID: 17616286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and characterization of ECM powder: implications for tissue engineering applications.
    Gilbert TW; Stolz DB; Biancaniello F; Simmons-Byrd A; Badylak SF
    Biomaterials; 2005 Apr; 26(12):1431-5. PubMed ID: 15482831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation and aerosolisation of mannitol particles produced via confined liquid impinging jets.
    Tang P; Chan HK; Chiou H; Ogawa K; Jones MD; Adi H; Buckton G; Prud'homme RK; Raper JA
    Int J Pharm; 2009 Feb; 367(1-2):51-7. PubMed ID: 18848874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.